Kaliumchlorid Noridem

Potassium chloride, the active ingredient in Kaliumchlorid Noridem, is an electrolyte presented as an injectable solution for intravenous use. It restores normal serum potassium levels and treats hypokalemia in patients requiring intravenous therapy.

GNH USA supplies Kaliumchlorid Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaliumchlorid Noridem, an intravenous electrolyte, is used to correct potassium deficits.

- Hypokalemia: restores serum potassium to the normal range in patients with low potassium levels. - Potassium supplementation during intravenous therapy: provides necessary potassium ions when oral intake is inadequate. - Cardiac arrhythmia risk management: helps maintain electrolyte balance to reduce the risk of arrhythmias in patients receiving diuretics.

Common Side Effects: - Infusion site pain or irritation: discomfort at the injection site. - Hyperkalemia: elevated serum potassium if over‑infused. - Nausea or vomiting: gastrointestinal upset. - Muscle weakness or cramps: transient neuromuscular symptoms. - Transient hypotension: mild drop in blood pressure during infusion.

Serious or Rare Side Effects: - Cardiac arrest or severe arrhythmias: life‑threatening rhythm disturbances. - Anaphylaxis: severe allergic reaction requiring immediate treatment. - Vein thrombosis or phlebitis: inflammation or clot in the infused vein. - Severe hyperkalemia leading to muscle paralysis. - Metabolic acidosis: significant shift in acid‑base status.

When using Kaliumchlorid Noridem, clinicians should consider several safety measures. - Monitor serum potassium: check levels before and during therapy. - Adjust dose in renal impairment: reduce or avoid if kidney function is compromised. - Avoid rapid infusion: administer over the recommended time to prevent cardiac events. - Use with caution in patients on ACE inhibitors, ARBs, or potassium‑sparing diuretics. - Contraindicated in hyperkalemia: do not give if serum K⁺ >5.5 mEq/L. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - ACE inhibitors, ARBs, potassium‑sparing diuretics: may cause dangerous hyperkalemia. - NSAIDs in renal failure: reduce potassium excretion and increase risk. - Succinylcholine: can cause abrupt potassium release.

Moderate Interactions (Monitor Closely): - Digoxin: potassium levels influence digoxin toxicity. - Beta‑blockers: may mask symptoms of hypokalemia. - Insulin therapy: shifts potassium intracellularly, affecting serum levels. - Corticosteroids: can alter electrolyte balance. - Loop diuretics: increase potassium loss, requiring careful monitoring.